Peripheral Artery Disease Market Worth $5,715.12 Million by 2027 | Growth & Key Business Strategies

According to a new report published by Allied Market Research, titled, "Peripheral Artery Disease Market: Global Opportunity Analysis and Industry Forecast, 2020-2027" the peripheral artery disease market accounted for $3,524.77 million in 2019, and is expected to reach $5,715.12 million by 2027, registering a CAGR of 8.5% from 2020 to 2027. Peripheral arterial disease (PAD) is a common circulatory problem in which narrow arteries reduce blood flow to the organs. PAD usually affects the arteries in the legs and sometimes affects the arteries that carry blood from the heart to the head, arms, kidneys and abdomen. This is due to the accumulation of fat (plaques) in the walls of the arteries, which reduces blood flow to the limbs, limbs and head.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐨𝐮𝐜𝐡𝐞𝐫: https://www.alliedmarketresearch.com/request-sample/4315

COVID-19 Impact Analysis:
The peripheral artery disease market is negatively impacted by the pandemic as most countries adopted lockdown to combat the pandemic. In addition, the American College of Surgeons (ACS) has recently developed guidelines for triage of vascular surgery patients, suggesting that non-emergency peripheral vascular procedures such as endovascular therapy for claudication should be postponed. Moreover, in regions severely affected by COVID-19, vascular procedures have been reduced to life or limb salvaging cases, owing to new government directives or hospital guidelines. All these factors are anticipated to impact the peripheral artery disease market as well in the future.

Factors such as rapid growth in the geriatric population and subsequent increase in the prevalence of peripheral arterial disease led to an increase in the peripheral arterial disease market due to increased production approvals. In addition, the increasing incidence of diabetes leads to an increase in the peripheral arterial disease market. However, the problem of restenosis (recurrence of peripheral artery disease even after treatment) hinders market growth. Constantly changing lifestyle habits such as healthy eating habits, excessive alcohol consumption, obesity, smoking and lack of physical activity also lead individuals to suffer from peripheral arterial disease and thus increase the market. For example, according to the American Heart Association, peripheral arterial disease (PAD) affects 8.5 million Americans each year.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/4315

Asia-Pacific is anticipated to be the most lucrative market for peripheral arterial disease. Major factors that attribute toward the fastest growth of this region is presence of large patient pool with unmet medical needs. In addition, growth in healthcare scenario in Asian countries, coupled with growth in GDP and government initiativesare expected to boost growth ofthe peripheral arterial disease market.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:
• The study provides an in-depth analysis of the peripheral artery disease market along with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing peripheral artery disease market opportunities.
• The key market players and their strategies have been analyzed to understand the competitive outlook of the peripheral artery disease market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.alliedmarketresearch.com/request-for-customization/4315

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
• Abbott Laboratories
• Angiodynamics, Inc.
• B. Braun Melsungen Ag
• Boston Scientific Corporation
• Becton, Dickinson And Company
• Cardinal Health, Inc.
• Cook Medical, Inc.
• Terumo Corporation

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Internet of Things in Healthcare Market: https://www.alliedmarketresearch.com/iot-healthcare-market

Surgical Sutures Market: https://www.alliedmarketresearch.com/surgical-sutures-market

Medical Tourism Market: https://www.alliedmarketresearch.com/medical-tourism-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

This release was published on openPR.